ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR CROHN’S DISEASE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

Stefan Schreiber  ¹     Corey A Siegel  ²     Keith Friedenberg  ³     Ursula Seidler  ⁴     Bal R. Bhandari  ⁵     Ziad Younes  ⁶     KE WANG  ⁷     Matthew McKevitt     Sally Zhao     Bittoo Kanwar     John Sundy     Scott D. Lee     Edward V Loftus Jr    
¹ Christian-Albrechts-University Kiel,Kiel,Germany
² Dartmouth-Hitchcock Medical Center,Lebanon,United States of America
³ Great Lakes Gastroenterology,Mentor,United States of America
⁴ Hannover Medical School,Hannover,Germany
⁵ Delta Research Partners,Monroe,United States of America
⁶ GastroOne,Germantown,United States of America
⁷ Gilead S

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)